awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38455525-73059A26-7B26-4ABA-ABD6-A22C22EC44D8
Q38455525-73059A26-7B26-4ABA-ABD6-A22C22EC44D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38455525-73059A26-7B26-4ABA-ABD6-A22C22EC44D8
Linifanib: current status and future potential in cancer therapy.
P2860
Q38455525-73059A26-7B26-4ABA-ABD6-A22C22EC44D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38455525-73059A26-7B26-4ABA-ABD6-A22C22EC44D8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
862aca1383c240f3583807716bd2cd9ff29d0305
P2860
A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC).